Indo Us Bio-Tech Limited (BOM:541304)

Indo Us Bio-Tech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	2.48	10.98	1.9	0.49	1.34
Cash & Short-Term Investments	2.48	10.98	1.9	0.49	1.34
Cash Growth	-77.44%	479.59%	285.03%	-63.38%	-32.93%
Accounts Receivable	150.01	190.45	247.42	205.47	247.06
Other Receivables	-	1.75	0.9	-	-
Receivables	150.01	192.2	248.32	205.47	247.06
Inventory	706.86	517.35	269.13	233.57	118.8
Prepaid Expenses	0.38	0.34	0.16	0.47	0.55
Other Current Assets	7.54	10.04	79.58	28.38	13.6
Total Current Assets	867.27	730.91	599.09	468.38	381.35
Property, Plant & Equipment	102.34	104.7	87.35	78.77	43.56
Long-Term Deferred Tax Assets	6.96	6.59	5.85	4.2	2.6
Long-Term Deferred Charges	-	-	-	-	0.14
Other Long-Term Assets	1.86	2.36	2.36	4.82	9.42
Total Assets	978.43	844.56	694.65	556.16	437.07
Accounts Payable	11.62	43.88	13.96	21.57	89.4
Accrued Expenses	-	2.57	2	2.58	2.54
Short-Term Debt	-	103.84	83.74	68.23	71.87
Current Portion of Long-Term Debt	119.02	11.39	15.21	22.83	9.27
Current Income Taxes Payable	3	3.52	0.97	0.97	0.75
Other Current Liabilities	29.75	9.45	7.05	6.66	7.09
Total Current Liabilities	163.39	174.64	122.93	122.84	180.92
Long-Term Debt	29.34	28.02	17.05	37.33	34.53
Other Long-Term Liabilities	-	13.99	9.29	10.55	7.86
Total Liabilities	193.24	217.09	149.69	171.09	223.65
Common Stock	200.52	200.52	100.26	91.67	60.68
Additional Paid-In Capital	-	221.19	221.19	146.02	42.34
Retained Earnings	-	205.76	223.5	147.38	110.4
Comprehensive Income & Other	584.67	-	-	-	-
Total Common Equity	785.19	627.47	544.96	385.07	213.42
Minority Interest	-	-	-	0.01	0
Shareholders' Equity	785.19	627.47	544.96	385.08	213.42
Total Liabilities & Equity	978.43	844.56	694.65	556.16	437.07
Total Debt	148.36	143.24	115.99	128.39	115.67
Net Cash (Debt)	-145.89	-132.26	-114.1	-127.9	-114.33
Net Cash Per Share	-7.28	-6.60	-5.92	-10.45	-7.85
Filing Date Shares Outstanding	19.81	20.05	20.05	18.33	14.56
Total Common Shares Outstanding	19.81	20.05	20.05	18.33	14.56
Working Capital	703.88	556.27	476.16	345.54	200.43
Book Value Per Share	39.64	31.29	27.18	21.00	14.65
Tangible Book Value	785.19	627.47	544.96	385.07	213.42
Tangible Book Value Per Share	39.64	31.29	27.18	21.00	14.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.